ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GERN vs ZVRA // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Geron Corporation (NASDAQ) VS. Zevra Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: GERN 1 — ZVRA 4
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GERN VS. ZVRA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GERN ZVRA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -20.20% -32.30% +12.10 GERN /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -18.27% -0.40% -17.87 ZVRA /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 ZVRA /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.6 47.0 -16.40 ZVRA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 6.9x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $607.9M $615.2M -$7.3M ZVRA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GERN REV ZVRA REV GERN GROSS % ZVRA GROSS % GERN FCF ZVRA FCF
FY 2025 $0 $0 — — -$111.0M -$2.4M
FY 2024 $0 $0 — — -$219.3M -$69.7M
FY 2023 $237.0K $0 — — -$167.7M -$33.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GERN // BETA —
ZVRA // BETA —